Hound Partners - IBERE PHARMACEUTICALS ownership

IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 24 filers reported holding IBERE PHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Hound Partners ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q3 2021$498,000
-0.6%
49,8670.0%0.03%
+8.3%
Q2 2021$501,000
+1.6%
49,867
-0.3%
0.02%
+4.3%
Q1 2021$493,00050,0000.02%
Other shareholders
IBERE PHARMACEUTICALS shareholders Q4 2021
NameSharesValueWeighting ↓
Hartree Partners, LP 1,285,000$12,875,700,0003.00%
Wealthspring Capital LLC 231,182$2,317,0000.50%
KRYGER CAPITAL Ltd 385,240$3,860,0000.22%
Schechter Investment Advisors, LLC 210,692$2,111,0000.19%
Sage Mountain Advisors LLC 89,180$894,0000.11%
Context Capital Management, LLC 115,053$1,153,0000.09%
Magnetar Financial LLC 784,909$7,865,0000.08%
ARISTEIA CAPITAL, L.L.C. 350,000$3,507,0000.06%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 36,569$366,0000.05%
Bulldog Investors, LLP 15,000$150,0000.04%
View complete list of IBERE PHARMACEUTICALS shareholders